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Elena Porta Dapena,7 Kurston Doonanco,8 Norma Leonard,8 Faten Tinsa,9 Ste´phanie Moortgat,10
Hakan Ulucan,11 Erkan Koparir,12 Ender Karaca,13 Nicholas Katsanis,5 Valeria Marton,14
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Circumferential skin creases Kunze type (CSC-KT) is a specific congenital entity with an unknown genetic cause. The disease phenotype
comprises characteristic circumferential skin creases accompanied by intellectual disability, a cleft palate, short stature, and dysmorphic
features. Here, we report that mutations in either MAPRE2 or TUBB underlie the genetic origin of this syndrome. MAPRE2 encodes a
member of the microtubule end-binding family of proteins that bind to the guanosine triphosphate cap at growing microtubule plus
ends, and TUBB encodes a b-tubulin isotype that is expressed abundantly in the developing brain. Functional analyses of the TUBBmu-
tants show multiple defects in the chaperone-dependent tubulin heterodimer folding and assembly pathway that leads to a compro-
mised yield of native heterodimers. The TUBB mutations also have an impact on microtubule dynamics. For MAPRE2, we show that
themutations result in enhancedMAPRE2 binding tomicrotubules, implying an increased dwell time at microtubule plus ends. Further,
in vivo analysis ofMAPRE2mutations in a zebrafish model of craniofacial development shows that the variants most likely perturb the
patterning of branchial arches, either through excessive activity (under a recessive paradigm) or through haploinsufficiency (dominant
de novo paradigm). Taken together, our data add CSC-KT to the growing list of tubulinopathies and highlight howmultiple inheritance
paradigms can affect dosage-sensitive biological systems so as to result in the same clinical defect.Introduction
Congenital symmetrical circumferential skin creases are
rare disorders, characterized by the folding of excess skin,
which leads to ringed creases, mostly of the limbs. This
feature was first described in 1969 by Ross, who introduced
the unfortunate term ‘‘Michelin tire baby.’’1 Subsequent
reports described variable additional features of the
Michelin-tire-baby syndrome (MIM: 156610), such as in-
tellectual disability (ID), facial dysmorphism, and cardiac
and genital anomalies.2–11 Previously, we described two
unrelated young individuals with an identical phenotype
consisting of circumferential skin creases, cleft palate,
facial dysmorphism, growth retardation, and ID and pro-
posed the term ‘‘circumferential skin creases Kunze type’’
(CSC-KT), based on the phenotype’s resemblance to the
original cases reported by Kunze and Riehm, to distinguish
this specific syndrome from other affected individuals
presenting with the same skin phenotype.6,7 Given the
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syndrome.
Here, we report that mutations in TUBB or in MAPRE2
underlie this genetic condition. TUBB is one of nine
b-tubulin-encoding genes present in the human genome
and is expressed widely among mammalian tissues; it has
a particularly pronounced abundance in the developing
CNS.12 Tubulins constitute the structural units of microtu-
bules, which are essential for a number of cellular processes
including intracellular trafficking, chromosome separa-
tion, and cell migration.13 MAPRE2 encodes a member of
the microtubule end-binding family of proteins that bind
to the GTP cap at growing microtubule plus ends and
either contribute to the regulation of microtubule dy-
namics or to microtubule reorganization during cell differ-
entiation.14 We show that mutations in MAPRE2 or TUBB
result in either an altered affinity of MAPRE2 for microtu-
bules or defects in the assembly of TUBB into tubulin
heterodimers. In addition, in vivo functional studies in
zebrafish gave us insight into the pathophysiological effectm; 2Laboratory for Genetics of Cognition, Department of Human Genetics,
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Table 1. Overview of MAPRE2 and TUBB Mutations and Clinical Features Present in Individuals Included in This Study
M2 M8 M9 M1 M3 M11 M15
Country of origin Spain Tunisia Belgium Belgium Canada Norway Turkey
Gene (NCBI Genome
browser GRCh38)
MAPRE2 (GenBank: NM_014268.3) TUBB (GenBank: NM_178014.3)
Mutation c.203A>G (p.Asn68Ser) c.260A>G (p.Tyr87Cys) c.427C>T (p.Arg143Cys) c.454C>T (p.Gln152*) c.43C>A (p.Gln15Lys) c.43C>A (p.Gln15Lys) c.665A>T (p.Tyr222Phe)
Inheritance homozygous, parents are
heterozygous carriers
homozygous, parents’
DNA not available
heterozygous, de novo heterozygous,
maternally inherited
de novo de novo de novo
Parents affected? father might have had
minor folds as a baby
no no mother has mild
cognitive impairment,
similar facial
phenotype
no no no
Parents
consanguineous?
yes yes no no no no yes
Clinical Features
Age at assessment 15 months 19 years 8 years and 9 months 6 years 15 years 5 years and 6 months 18 months
Length, at birth 52.5 cm (0 SD) 47 cm (2.3 SD) 47 cm (2 SD) 48 cm (1.5 SD) 48 cm (2 SD) 53 cm (þ0.5 SD) 48 cm (1.5 SD)
Length, current 77 cm (-1 SD) 120 cm (<3 SD) 126 cm (1.5 SD) 108 cm (2 SD) 168 cm (1 SD) 103.5 cm (2.8 SD) nt
OFC, at birth 36 cm (0 SD) 32.5 cm (2.5 SD) 32.8 cm (2 SD) 33 cm (2 SD) 31.5 cm (<2.5 SD) 36.5 cm (þ0.5 SD) nt
OFC, current 47 cm (-0.5 SD) 49 cm (<3 SD) 52 cm (0 SD) 49.5 cm (1 SD) 51 cm (<2.5 SD) 41 cm (<3 SD) 43 cm (<2.5 SD)
Cleft palate cleft palate cleft palate no cleft palate cleft palate cleft palate high palate, no cleft
Creases limbs and neck limbs; improvement,
but visible
limbs; disappeared
around age 4 years
limbs; spontaneous
improvement
limbs, fingers, neck,
penis; improved at
follow-up, but visible
limbs and neck;
disappeared at age
4 years; still creases
on wrists
limbs
Other dysmorphisms flat face, microphthalmia,
short palpebral fissures,
epicanthal folds, low
broad nasal bridge, low-
set, small dysplastic ears,
hypoplastic scrotum,
coronal hypospadias
elongated face,
hypertelorism, bilateral
epicanthic folds,
upslanting palpebral
fissures, microphthalmia,
strabismus, wide nasal
bridge, aberrant teeth,
low-set posteriorly
rotated ears with
overfolded thick helices,
short neck, widely
spaced nipples,
hypospadias,
undescended testes,
second and third toe
syndactyly
flat face, low set anterior
hairline, microphthalmia,
bilateral epicanthic folds,
small downslanting
palpebral fissures, ptosis,
synophris, broad nasal
bridge, dysplastic small,
low-set and posteriorly
rotated ears with
overfolded helices,
upturned ear lobes;
microstomia with thin
upper lip, small chin,
short hands, tapering
fingers
microphthalmia with
small upslanting
palpebral fissures,
epicanthal folds,
broad nasal bridge,
flat midface, small
mouth, small chin,
clinodactyly of fifth
fingers
microphthalmia, short
palpebral fissures,
epicanthal folds, flat
supraorbital ridge, low
nasal bridge, long
philtrum, small
mouth, small low-set
posteriorly rotated
malformed ears with
thick overfolded
helices, brachycephaly,
wide-spaced nipples
short palpebral fissures,
blepharophimosis,
broad nasal bridge
with epicanthal folds,
flat face, small mouth,
mild asymmetry in
face and abdomen,
low-set dysmorphic
and posteriorly
rotated ears, short
neck, long fingers
elongated flat face,
hypertelorism, upslanting
short palpebral fissures,
epicanthus, periorbital
fullness, long eyelashes,
blepharophimosis, broad
and depressed nasal
bridge, malformed low-
set ears, microstomia,
down-turned corners of
the mouth, wide-spaced
nipples, second and third
toe syndactyly
(Continued on next page)
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792 The American Journal of Human Genetics 97, 790–800, Decembof the different MAPRE2 mutations during craniofacial
development.Subjects and Methods
Subjects
Through previously published case reports and collaboration, DNA
from seven unrelated individuals with CSC-KT had been collected,
as well as parental DNA when available. Written informed consent
was obtained from all parents on behalf of the affected individual.
This studywasapprovedbytheKULeuvenethicalboardcommission.
Clinical details are summarized in Table 1.
Exome Sequencing and Data Analysis
Genomic DNA was extracted from peripheral blood via standard
methods. DNA library preparation and exome capturing were per-
formed for two subject-parent trios and two isolated subjects.
Samples were sequenced on an Illumina HiSeq2000 platform, and
the acquired reads were aligned to the reference human genome
(UCSC Genome Browser hg19). Data processing was performed
with the Genome Analysis Toolkit, and variants were annotated
with Annovar and an in-house-developed web interface called
Annotate-it.15–17 Variants were restricted to rare and novel variants
and filtered according to a de novo or recessive hypothesis. Inter-
esting candidate variants were validated with Sanger sequencing.
Sanger Sequencing
PCR amplification and Sanger sequencing of the complete coding
regions of MAPRE2 and TUBB, including exon-intron boundaries,
and 50 UTRs was performed. Primers are available on request.
Binding of MAPRE2 Proteins to Microtubules
Wild-type andmutant forms ofMAPRE2were generated by coupled
transcriptionand translation inrabbit reticulocyte lysate (TnTQuick
Coupled Transcription/Translation System; Promega) containing 35
S-methionine (specific radioactivity, 10 mCi/mMole), according to
the manufacturer’s recommendations. The reactions were cleared
of particulate material by centrifugation at 200,0003 g at 4C in a
Beckman Optima ultracentrifuge. Bovine brain tubulin depolymer-
ized by incubation on ice in 50mMPIPES buffer (pH6.8) and centri-
fugation at 100,0003 g to remove aggregated material was added
to the cleared translation cocktail, and the mixture was adjusted to
approximately physiological ionic strength by addition of NaCl to
a final concentration of 0.2 M. Polymerization was induced by the
addition of GTP to 1 mM and glycerol (containing 0.2M NaCl) to
40% and incubation at 37C for 30min. The reactions were diluted
5-fold with 50mMPIPES buffer containing 0.2MNaCl, 1 mMGTP,
and 10 mM taxol (the latter was present to stabilize polymerizedmi-
crotubules) and loadedonto cushions (1.0ml) of PIPES-buffered1M
sucrose also containing 0.2 M NaCl and taxol. Microtubules were
recovered by centrifugation for 10min at 200,0003 g; microtubule
pellets were analyzed by 8% SDS-PAGE. Gelswere stainedwithCoo-
massie blue, dried, and subjected to autoradiography.
Folding and Limited Proteolysis Experiments
In the case of TUBB, folding and assembly of wild-type andmutant
forms was followed kinetically in coupled transcription and trans-
lation reactions as described previously.12 In the case of MAPRE2,
coupled transcription and translation reactions (10 ml) driven by
plasmids encoding wild-type and mutant forms were done iner 3, 2015
the presence of 35S-methionine (specific radioactivity, 10 mCi/
mMole), under the conditions recommended by themanufacturer
(Promega). Reaction products were diluted to 0.1 ml by the addi-
tion of buffer (20 mM Tris-HCl [pH 7.5], 0.2 M NaCl, 1 mM
DTT) and were centrifuged at 200,0003 g for 10 min to remove
all particulate material, and the supernatants were applied to a
Superdex 200 HR 10/20 gel filtration column (GE Healthcare)
equilibrated and run in the same buffer. Aliquots (0.1 ml) of frac-
tions (0.5 ml) emerging from this column were analyzed for their
radioactivity content by scintillation counting. Material con-
tained in the major radioactive peak was detected by autoradiog-
raphy after SDS-PAGE. In experiments to compare the susceptibil-
ity of wild-type and mutant forms of MAPRE2 to proteolysis,
labeled wild-type and mutant forms generated by coupled tran-
scription and translation as described above were subjected to
limited digestion by proteinase K, and the reaction products
were analyzed by SDS-PAGE as described previously.18
Neuro-2a Cell Transfection, Immunostaining, and
Surface-Area Quantification
Neuro-2a cells were cultured and transfected as described previ-
ously.12 Mutant constructs were generated with a site-directed
mutagenesis kit (Quickchange Lightning; Agilent Technologies).
Immunostaining employing an anti-a-tubulin antibody (ab7291,
1:1,000; Abcam,) and an anti-FLAG antibody (ab1162, 1:1,000;
Abcam) was performed as previously described.12 For detection
of the primary antibodies Alexa-488 and Alexa-568, labeled sec-
ondary antibodies (Molecular Probes) were employed. For the
determination of surface areas, cells (nR 18 cells for each condi-
tion) were imaged and their area wasmeasured with ImageJ. Statis-
tical analysis (one-way ANOVA with Bonferroni post hoc test for
multiple comparisons) was performed with GraphPad Prism. Im-
ages were acquired on a Zeiss LSM 710.
Live Cell Imaging and Analysis of EB3 Comets
Neuro-2a cells were seeded in 35 mm glass-bottom culture dishes
(MatTek Corporation) that were coated with Poly-L-Lysine. Cell
culture medium was exchanged with imaging medium (DMEM
with no phenol red [GIBCO Life Sciences], 10% fetal bovine serum
[Sigma], and 1% L-Glutamine [Sigma]), and dishes were placed in
themicroscope stage incubator (37C, 5%CO2) for 30min prior to
image acquisition. Images were acquired with a spinning disc
confocal microscope UltraVIEW VoX (PerkinElmer) mounted on
an AXIO Observer Z1 (Zeiss) by scanning bidirectionally at three
Z-positions with 0.3 mm spacing every second for 2 min. Recorded
stacks were analyzed with ImarisTrack 7.4 (Bitplane) by applica-
tion of an automatic tracking algorithm. The analyzed region of
interest was selected manually. Statistical analyses were done
with GraphPad Prism 6, applying a one-way ANOVA and a Bonfer-
roni post hoc test after pooling the data of at least 16 cells from
four different imaging days (see Table S1).
Plasmid Preparation and In Vitro Transcription
We obtained a commercial MAPRE2 open reading frame (ORF)
clone corresponding to the full-length human transcript
GenBank: NM_014268.3 (NCBI Genome browser GRCh38)
(IOH5850, Ultimate ORF Clones; Invitrogen). We conducted site-
directed mutagenesis to generate mutant constructs according to
the manufacturer’s instructions (QuikChange Site-Directed Muta-
genesis Kit, Agilent) and sequence confirmed the resulting vectors.
Wild-type and mutant ORF constructs were subsequently clonedThe Americaninto the pCS2þ vector, linearized with NotI, and in vitro tran-
scribed with the SP6 mMessage mMachine kit (Ambion).
Zebrafish Embryo Injections
We obtained two splice-blocking antisense morpholino oligonucle-
otides (MOs) targeting mapre2 exon 2 (e2i2; 50-GAGCTTCACA
TACCTGACGACAGCT-30) and exon 3 (e3i3; 50-TGATGTCGGCT
CACCTTATCAACAT-30) splice-donor sites, respectively. To test MO
efficiency, wild-type (AB background) zebrafish embryos were in-
jected with 1 nl of increasing doses (4 ng, 6 ng, 8 ng) of MO at the
one-to-four cell stage (n ¼ 20 embryos per injection batch). At
1 day post-fertilization (dpf), embryoswereharvested inTrizol (Invi-
trogen) and total RNAwas extracted according to themanufacturer’s
instructions.We synthesized cDNAbyusing theQuantiTect Reverse
Transcription Kit (QIAGEN); we used the resulting cDNA as a tem-
plate for PCR tomonitor theMOeffectonmRNAsplicing. PCRprod-
ucts were separated by agarose gel electrophoresis, gel-purified, and
sequenced directly via Sangermethodology. For craniofacial pheno-
typing studies,wecollectedembryos fromnaturalmatingsofhetero-
zygous -1.4col1a1:egfp transgenic adults (AB) outcrossed with wild-
type (AB) adults.19 A 1 nl cocktail of either MO (6 ng e2i2 or 6 ng
e3i3) and/or 100 pg capped human MAPRE2 mRNA was injected
into embryo batches at the one-to-four cell stage (n ¼ 50–100 em-
bryos per injection batch) andmaintained at 28C in embryomedia
(0.3 g/L NaCl, 75 mg/L CaSO4, 37.5 mg/L NaHC03, 0.003%methy-
lene blue) and was screened for the transgene at 1 dpf.
Automated Zebrafish Imaging
Larvae were positioned and imaged live with the Vertebrate Auto-
mated Screening Technology (VAST; software version 1.2.2.8)
platform (Union Biometrica) in a manner similar to previously
described methods.20 Larvae from each experimental condition
were anesthetized with 0.2 mg/mL Tricaine prior to being loaded
into the sample reservoir. Dorsal and lateral image templates of
wild-type andmorphant larvae were created for each experimental
time point (2, 3, and 4 dpf) and compared to each larva in the capil-
lary; images were acquired at a >70% minimum similarity for
the pattern-recognition algorithms. All VAST operational mode
settings were set to ‘‘auto,’’ including rotational position, high-res-
olution imaging, output, and bubbles and debris. Once recognized
inside the 600 mmborosilicate capillary of the VASTmodule on the
microscope stage (AxioScope A1, Zeiss), the larvae were rotated
180 to capture a ventral image via a 53 fluar objective and fluores-
cent excitation at 470 nm to detect GFP (Axiocam 503 monochro-
matic camera, Zen Pro software; Zeiss). After imaging, the larvae
were transferred to a collection beaker with fresh embryo media
then stored at 28C until subsequent imaging time points.
Zebrafish Phenotypic Analysis
Weassessed craniofacial patterning by eithermeasuring the angle of
the ceratohyal cartilage (2, 3, and 4 dpf) or by counting the number
of ceratobranchial archpairs visible at3dpf. Pairwise comparisons to
determine statistical significanceweremade via a Student’s t test (ce-
ratohyal measurements) or a c-squared test (ceratobranchial-arch-
pair counts). Experiments were repeated at least twice.Results
Identification of Mutations in TUBB and MAPRE2
We performed whole-exome sequencing in four unre-
lated individuals with CSC-KT (Figure 1, Table 1). OneJournal of Human Genetics 97, 790–800, December 3, 2015 793
Figure 1. Clinical Features of Affected Individuals with a MAPRE2 or TUBB Mutation
(A and B) Facial phenotype of individual M9 with MAPRE2 p.Arg143Cys substitution.
(C) Individual M9 at the age of 6 years.
(D–F) Individual M11 with a TUBB p.Gln15Lys substitution.
(G and H) Individual M3 with a TUBB p.Gln15Lys substitution and at the age of 15 years.
(I and J) Individual M11 at the age of 5.5 years.
Note the circumferential skin creases on arms and legs, most pronounced at a young age, and the similar facial features including hyper-
telorism, small palpebral fissures, and low-set ears with overfolded helices and prominent lobes. For a detailed description, see Table 1.heterozygous nonsense mutation (c.454C>T [p.Gln152*])
and two homozygous missense mutations (c.203A>G
[p.Asn68Ser] and c.260A>G [p.Tyr87Cys]) in MAPRE2
(MIM: 605789), encoding a microtubule-associated pro-
tein, member 2, from the rp/eb family, were identified in
three of the four individuals (Table 1). None of the muta-
tions were present in the 1000 Genomes, Exome Variant
Server, or Exome Aggregation Consortium (ExAC) data-
bases. All affected residues were highly conserved and pre-
dicted to be deleterious by various in silico methods.21–23
Sequencing of the coding sequence and intron-exon
boundaries of MAPRE2 in three additional individuals
with CSC-KT led to the identification of one additional de
novomissensemutation, c.427C>T (p.Arg143Cys), in indi-794 The American Journal of Human Genetics 97, 790–800, DecembvidualM9 (Table 1). Next, we re-analyzed the exome data of
individual M3, in whom we failed to identify a MAPRE2
mutation, for mutations in other genes that encode
proteins associated with microtubule biology. This re-
vealed a de novo mutation, c.43C>A (p.Glu15Lys), in the
b-tubulin-encoding geneTUBB (MIM:191130). Sequencing
of TUBB in the remaining two CSC-KT-affected individuals
also identified de novo missense mutations (c.665A>T
[p.Tyr222Phe] and c.43C>A [p.Glu15Lys]), one of which
was identical to the mutation in individual M3 (Table 1).
MAPRE2 Mutations Affect Microtubule Binding
The dynamic behavior of microtubules is subject to regula-
tion by several factors, including the local concentrationer 3, 2015
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(legend continued on next page)
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of heterodimers available for incorporation, post-transla-
tional modifications, the binding of associated proteins to
the microtubule polymer, and transient interactions of
the GTP cap with members of a sizable family of proteins
termedþTIPs.24–26 Among these, the EB family of proteins,
towhichMAPRE2 belongs, is among the best characterized;
they bind to microtubule plus ends and act as a link to a
network of other þTIPs that regulate interactions of micro-
tubules with a spectrum of cell structures and organelles.27
Unlike MAPRE1 and MAPRE3, MAPRE2 does not pro-
mote microtubule growth or suppress catastrophe; rather,
MAPRE2 is critical for microtubule reorganization during
early stages of apico-basal epithelial differentiation.14 We
explored the mechanism of defective function conferred
by the mutations we identified. In the case of MAPRE2, we
first examined the ability of the mutant proteins to fold to
thenative state aswell as their structural integrity.We found
no detectable differences in the behavior of wild-type and
mutant proteins when newly translated sequences were
analyzed by gel filtration (Figure S1A). Similarly, kinetic
analysis of reactions inwhich theseproteinswere incubated
with the non-specific protease proteinase K revealed no dif-
ference between wild-type andmutant proteins in terms of
vulnerability to degradation (Figure S1B).We conclude that
none of the MAPRE2 mutations significantly compromise
the secondary or tertiary structure of the protein.
We next considered the possibility that theMAPRE2mu-
tationsmight affectmicrotubulebinding, given that all four
MAPRE2mutationswe identified reside in the calponin-ho-
mology (CH) domain of the protein, previously shown to
be responsible for interaction with microtubules.28 To test
this hypothesis, 35S-methionine labeled wild-type and
mutant MAPRE2 proteins were compared for their ability
to co-polymerize with equal aliquots of unfractionated
depolymerizedbovinebrainmicrotubules. Because the stoi-
chiometric ratio of input labeledMAPRE2 to tubulin is iden-
tical in each reaction, this experiment showed that, under
physiological conditions of ionic strength, therewas signif-
icantly enhanced binding of mutant proteins (4-fold in the
case of p.Asn68Ser and p.Tyr87Cys and about 2-fold in the
case of p.Arg143Cys) to microtubules in comparison to
binding of the wild-type control proteins to microtubules
(Figure 2A). These data imply an increased dwell time at
microtubule plus ends, which could influence the initial(B) Analysis by SDS-PAGE of 35S-labeled wild-type andmutant TUBB p
all TUBB sequences.
(C) Kinetic analysis of TUBB heterodimer assembly reactions. Arrows s
assembly pathway, each assigned on the basis of their characteristic
between the wild-type and mutant reactions, including a relative red
(D) Localization of FLAG-tagged wild-type and TUBB mutants in cult
green, with DM1alpha antibody for endogenous tubulin in red and H
for FLAG and DM1alpha staining in gray scale andmagnifications of t
Note that the wild-type FLAG-tagged TUBB, as well as both mutants
(E) Still image of a Neuro-2a cell transfected with EB3-mCherry. Note t
see also Movies S1, S2, and S3).
(F) Quantification of comet speeds in Neuro-2a cells transfected with
mutant TUBB (p.Tyr222Phe and p.Gln15Lys). nR 16 cells, nR 1651
bars show SEM.
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Mutations in TUBB Compromise Heterodimer
Assembly and Microtubule Dynamics
Mutations that affect the C-terminal domain of TUBB have
been previously reported to cause microcephaly with struc-
tural brain malformations (MIM: 615771).12 In contrast,
the mutations identified in this study affect the N-terminal
part of the protein. Like all a- and b-tubulins, newly synthe-
sized TUBBpolypeptides cannot formheterodimerswithout
facilitation via interactionwith a series ofmolecular chaper-
ones, including prefoldin (PFD), the cytosolic chaperonin
CCT, and five tubulin-specific chaperones termed TBCA-E
that function collectively as a GTP-dependent hetero-
dimer-assembly nanomachine.18 To establish the mecha-
nistic basis of defects caused by the newly identified TUBB
mutations, we investigated their influence on the chap-
erone-dependent assembly of the a/b-tubulin heterodimer.
To do this, the folding and assembly of wild-type and
mutant-bearing TUBB polypeptides were followed kineti-
cally in coupled in vitro transcription and translation reac-
tions and the various intermediates were resolved on non-
denaturing polyacrylamide gels.12,18 For wild-type TUBB,
the kinetic analysis showed the characteristic flow of label
from the PFD/b- and CCT/b-tubulin binary complexes to
TBCA/b-tubulin and TBCD/b-tubulin, respectively, and ulti-
mately to de novo assembled heterodimers (Figure 2C). In
the case of the p.Tyr222Phe substitution, however, the yield
of TBCA/b was greatly diminished, as was the yield of de
novo assembledheterodimers. In the case of the p.Gln15Lys
substitution, we found a profound reduction in the forma-
tionof theTBCD/b-tubulin intermediateandanevengreater
reduction (compared to thewild-type control and p.Tyr222-
Phe) in the yield of de novo assembled heterodimers
(Figure 2C). We conclude that both the TUBB mutations
we describe here result in defective interactions with the
chaperones that participate in de novo heterodimer assem-
bly. However, we found that those heterodimers that did
form were capable of co-polymerization into the microtu-
bule cytoskeleton upon expression in cultured Neuro-2a
cells and NIH 3T3 fibroblasts (Figure 2D, Figure S2).
To assess the potential effect of the TUBB mutations on
microtubule dynamics in vivo, we measured the speed ofroteins. Note the indistinguishable translational efficiency among
how themigration positions of various intermediate species in the
electrophoretic mobility.18 Note various quantitative differences
uction in the yields of a/b heterodimer.
ured Neuro-2a cells. Staining with anti-FLAG antibody is shown in
oechst staining to visualize nuclei in blue. The individual channels
he boxed regions indicated in the color combine image are shown.
, are incorporated into the microtubule lattice. Scale bar, 10 mm.
he comets located at the plus tips of growingmicrotubules (arrows,
EB3-mCherry alone (control), or EB3-mcherry with wild-type or
tracks per condition. ***p< 0.001, ****p< 0.0001, nsp> 0.05. Error
er 3, 2015
microtubule plus ends by tracking EB3-mCherry comets
(Figure 2E).We first establishedmicrotubule co-localization
of FLAG-tagged TUBB wild-type and mutant tubulins with
EB3-mCherry in a co-transfection experiment in which
fixed cells were stained with an anti-FLAG antibody. Co-
localization was found in>98% of cases, and amorpholog-
ical assessment of cells transfected with wild-type and
mutant constructs showed no detectable difference
(Figure S2). The plus-end tracking experiments showed
that overexpression of wild-type TUBB resulted in a small
but significant increase of microtubule plus end velocity
(p < 0.001, relative to control, Figure 2F), consistent with
our previous results.29 This increase in EB3 velocity was
not observed in the p.Gln15Lys mutant (p < 0.0001, rela-
tive to wild-type, Figure 2F), whereas overexpression of
the p.Tyr222Phe mutant significantly decreased microtu-
bule plus end velocity, even below control EB3 levels (p <
0.0001, relative to EB3 control; Figure 2F, Table S1, and
Movies S1, S2, and S3). These data suggest that both TUBB
mutations compromise microtubule dynamics.
MAPRE2 Is Involved in Craniofacial Patterning in
Zebrafish
Microtubules areknown tobeessential forpropermigration
of the neural crest into the branchial arches during facial
and palatal development. The typical facial features
observed in individuals with CSC-KT, including cleft palate
and low-set and dysplastic ears, are reminiscent of defective
neural-crest cell migration. To investigate this possibility,
we coupled a zebrafish model of craniofacial development,
in which GFP marks the developing cartilage in live em-
bryos, with newly developed automated in vivo imaging
technology.19,20 Although reciprocal BLAST searches failed
to identify a clear ortholog for TUBB (due to the complexity
of the b-tubulin gene family), we identified a single recip-
rocal MAPRE2 ortholog in the D. rerio genome (78% iden-
tity, 85% similarity). Transientmapre2 suppression via two
non-overlapping, efficient splice-blocking MOs resulted in
quantifiable and reproducible defects in early craniofacial
patterning (Figure 3, Figure S3). First, we noted aberrant for-
mation of the angle between early bilateral cartilaginous
structures at 2 dpf, which persisted to a broadened angle
of the ceratohyal at 3 and 4 dpf as indicated byGFP-positive
cells in -1.4col1a1:egfp larvae (p < 0.0001 for all compari-
sons between controls and e2i2 or e3i3 MOs; Figures 3A
and 3B). Second, we detected a significant delay in rostro-
caudal ceratobranchial (cb) arch patterning, most evident
at 3 dpf. Whereas 94% of control larvae displayed at least
three cb arch pairs at this stage,morphants showed a signif-
icant reduction in these structures: only 8% or 22% ofmor-
phant larval batches had at least three equivalent pairs of
structures (e2i2 and e3i3 MOs, respectively, p < 0.0001;
Figure 3C). Importantly, the observed phenotypic concor-
dance between our MOs for two different readouts span-
ning three different time points suggested that their effects
were specific tomapre2 suppression, andwere unlikely to be
a result of off-target effects.The AmericanMotivated by our in vitro studies that suggested that the
MAPRE2 variants induced enhanced end-binding, we used
our in vivo craniofacial model to assess the functional con-
sequences of p.Asn68Ser and p.Arg143Cys-encoding vari-
ants by using in vivo complementation.30 Focusing on
the cb arch formation delay at 3 dpf as the most robust
phenotypic readout, we co-injected the e2i2 MO with
wild-type human MAPRE2 mRNA. We were able to signifi-
cantly rescue the cb arch patterning defect, indicating
phenotypic specificity (p < 0.0001, wild-type rescue versus
e2i2 MO alone; Figure 3D). Next, we compared the effi-
ciency of MO-induced phenotypic rescue between wild-
typemRNAandmRNAharboringeitherof the twomissense
mutations. The c.427C>T [p.Arg143Cys] mutation, occur-
ring de novo in individual M9, significantly improved the
presence of cb arches at 3 dpf, but was still significantly
worse than wild-type rescue, suggesting that this variant
causes partial loss of function in this assay. In contrast,
the recessively inherited c.203A>G [p.Asn68Ser] mutation
produced cb arch counts that were significantly improved
from the wild-type rescue larval batches (p < 0.0001 for
mutant versus wild-type rescue batches; n ¼ 29–53 larvae
per batch, repeated with similar results; Figure 3D). These
reproducible data suggest that the p.Asn68Ser substitution
gives rise to a hyperactive protein, suggesting that this
in vivo effect on craniofacial development might be corre-
lated with the four-fold increase in microtubule binding
for this change seen in our in vitro assay (Figure 2A). Impor-
tantly, expression of mutant mRNAs in the absence of e2i2
MO did not result in any appreciable craniofacial pheno-
types (97% and 84% with three or more cb arch pairs for
c.203A>G [p. Asn68Ser] and c.427C>T [p.Arg143Cys],
respectively, compared to 90% for wild-type mRNA alone;
Figure 3D), arguing against the possibility of these changes
having dominant-negative effects.
Tubb Is Expressed in Mouse Skin
Multiple circumferential skin folds of the limbs are rare
and should be differentiated from underlying nevus lipo-
matosis or smooth-muscle hamartoma.7 Clinical follow-
up showed that in the majority of affected individuals,
skin creases become less pronounced with age (Fig-
ure 1). Asymmetric cell division is known to drive the
development and differentiation of the skin and the
epidermis in particular, with a distinct role for microtu-
bules in spindle orientation and cell polarity.31 It is
conceivable that the circumferential skin creases observed
are a consequence of altered progenitor output associated
with defects in the plane of cell division.32 To investigate
this possibility, we explored whether Tubb is expressed in
the developing murine skin in 4-day-old mice. We ex-
ploited a BAC transgenic mouse model that drives GFP
expression under the endogenous Tubb promoter because
no specific antibodies are available for this protein. Immu-
nostaining with the m-phase marker (pH 3) revealed co-
localization with GFP in the proliferative layers of the
epidermis and in the developing hair follicle (Figure S4).Journal of Human Genetics 97, 790–800, December 3, 2015 797
AB
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Figure 3. In Vivo Analyses ofMAPRE2 Variants Indicate a Role in Craniofacial Patterning and Differing Functional Effects of Recessive
versus De Novo Variants
(A) Suppression ofmapre2 in zebrafish results in altered craniofacial patterning, including broadening of the ceratohyal (ch) and delay in
the formation of the ceratobranchial (cb) arches. Representative ventral views of -1.4col1a1:egfp control andmorphant larvae imaged live
at 2, 3, and 4 days post-fertilization (dpf). Scale bar, 200 mm.
(legend continued on next page)
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Discussion
Here, we have shown that mutations in either MAPRE2 or
TUBB can cause CSC-KT. This syndrome is characterized by
genetic heterogeneity but a highly similar and recogniz-
able clinical phenotype. Within our cohort, the two indi-
viduals with a homozygous MAPRE2 mutation (M2 and
M8) developed a more severe neurological involvement
consisting of severe ID and seizures, absent in the two in-
dividuals with a heterozygous MAPRE2 mutation (M1
and M9) and the individuals with a de novo TUBB muta-
tion (Table 1). We are reluctant to infer any possible geno-
type-phenotype correlations because a larger allelic series
would be necessary in order to do so.
Our genetic studies highlight two emergent themes in
rare genetic disorders. First, the mutations discovered
here in TUBB significantly extend the phenotypic spec-
trum of b-tubulin beyond microcephaly and structural
brain malformations.12 The CSC-KT individuals with a
TUBB mutation in our study do not show gross brain mal-
formations on imaging. On the contrary, the individuals
reported by Breuss et al. carry a more C-terminal TUBB
mutation and do not present the distinctive CSC-KT
craniofacial and skin phenotype.12 This observation raises
the possibility that the mutations discovered here affect
other or additional functions of the molecule, thus
inducing greater phenotypic pleiotropy.
Second, for MAPRE2, our studies revealed an initial ge-
netic conundrum, wherein the same clinical phenotype
can apparently be induced through either a recessive or
a de novo presumed paradigm. Our in vivo functional
studies potentially resolve this paradox by showing that
the de novo events most likely induced haploinsufficiency,
whereas the mutations inherited recessively impart
increased activity of the protein, presumably requiring a
threshold to be reached to trigger a pathological effect. In
this regard, we speculate that MAPRE2 exhibits a ‘‘Goldi-
locks effect’’ whereby, at least for the maturation of the
branchial arches, either excessive or insufficient protein
can cause mispatterning and, ultimately, the same clinical
pathology. Such dosage insufficiency has been reported
previously; for example, hyperactive or hypoactive com-
plement factor I (CFI) confers susceptibility to age-related
macular degeneration, and deletion or duplication of a
variety of copy-number variants can likewise give rise to
the same phenotype.33,34 Further studies will be required
to understand whether the mechanism of pathology is
the same for hypo- and hyperactive MAPRE2.(B) Measurement of the ch angle indicates abnormal formation of cra
dpf. Images were measured as shown in (A) (angle between dashed lin
parison to controls at the three time points assessed. n ¼ 20–48 emb
(C) Distribution of cb arch pairs at 3 dpf shows a significant delay for b
n ¼ 36–48 larvae per batch, repeated twice.
(D) In vivo complementation assay scoring cb arch pair counts at 3
morph, and the de novo c.427C>T (p.Arg143Cys) change is a hypom
erbative effect. n ¼ 29–53 larvae per batch, repeated.
*p < 0.0001.
The AmericanIn summary, our data add CSC-KT to an expanding com-
pendium of tubulinopathies and highlight the emergent
phenomenon in which multiple inheritance paradigms
can affect dosage-sensitive biological systems and cause
the same clinical defect.Supplemental Data
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